472 related articles for article (PubMed ID: 26976653)
1. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
2. Smith-Lemli-Opitz syndrome with a classical phenotype, oesophageal achalasia and borderline plasma sterol concentrations.
Haas D; Armbrust S; Haas JP; Zschocke J; Mühlmann K; Fusch C; Neumann LM
J Inherit Metab Dis; 2005; 28(6):1191-6. PubMed ID: 16435228
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Harrison FE; Ahsen R; Hart SE; Folkes OM; Mirnics K; Porter NA
Biol Psychiatry; 2014 Feb; 75(3):215-22. PubMed ID: 23896203
[TBL] [Abstract][Full Text] [Related]
5. Sterols in blood of normal and Smith-Lemli-Opitz subjects.
Ruan B; Wilson WK; Pang J; Gerst N; Pinkerton FD; Tsai J; Kelley RI; Whitby FG; Milewicz DM; Garbern J; Schroepfer GJ
J Lipid Res; 2001 May; 42(5):799-812. PubMed ID: 11352988
[TBL] [Abstract][Full Text] [Related]
6. 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.
Tomita H; Hines KM; Herron JM; Li A; Baggett DW; Xu L
Elife; 2022 Sep; 11():. PubMed ID: 36111785
[TBL] [Abstract][Full Text] [Related]
7. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Xu L; Sheflin LG; Porter NA; Fliesler SJ
Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
[TBL] [Abstract][Full Text] [Related]
8. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Koczok K; Horváth L; Korade Z; Mezei ZA; Szabó GP; Porter NA; Kovács E; Mirnics K; Balogh I
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439893
[TBL] [Abstract][Full Text] [Related]
10. Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients.
Liu W; Xu L; Lamberson CR; Merkens LS; Steiner RD; Elias ER; Haas D; Porter NA
J Lipid Res; 2013 Jan; 54(1):244-53. PubMed ID: 23072947
[TBL] [Abstract][Full Text] [Related]
11. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.
Xu L; Korade Z; Rosado JDA; Liu W; Lamberson CR; Porter NA
J Lipid Res; 2011 Jun; 52(6):1222-1233. PubMed ID: 21402677
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
[TBL] [Abstract][Full Text] [Related]
13. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
14. 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway.
Wassif CA; Yu J; Cui J; Porter FD; Javitt NB
Steroids; 2003 Aug; 68(6):497-502. PubMed ID: 12906934
[TBL] [Abstract][Full Text] [Related]
15. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
16. Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi.
Linck LM; Hayflick SJ; Lin DS; Battaile KP; Ginat S; Burlingame T; Gibson KM; Honda M; Honda A; Salen G; Tint GS; Connor WE; Steiner RD
Prenat Diagn; 2000 Mar; 20(3):238-40. PubMed ID: 10719329
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
[TBL] [Abstract][Full Text] [Related]
18. Identification of three patients with a very mild form of Smith-Lemli-Opitz syndrome.
Langius FA; Waterham HR; Romeijn GJ; Oostheim W; de Barse MM; Dorland L; Duran M; Beemer FA; Wanders RJ; Poll-The BT
Am J Med Genet A; 2003 Sep; 122A(1):24-9. PubMed ID: 12949967
[TBL] [Abstract][Full Text] [Related]
19. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
20. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Shelton R; Porter NA
J Lipid Res; 2010 Nov; 51(11):3259-69. PubMed ID: 20702862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
